Purslane extract effects on obesity-induced diabetic rats fed a high-fat diet

Malaysian Journal of Nutrition

Volumn 16, Issue 3, 2010, Pages 419-429

  Hussein, Mohammed Abdalla ^a  

^a 6th of October City   (Egypt)

Author keywords

Atherogenic index; Insulin resistance index; Purslane

Indexed keywords

PORTULACACEAE; RATTUS;

EID: 79851500899     PISSN: 1394035X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Ahmed M, Alierza G & Mahboobeh V (2007). Hypocholesterolemic effects of purslane extract on serum lipids in rabbits fed with high cholesterol levels. Int J Pharmacol 3: 285-289.
2. Al-Howiriny T (2008). Protective effect of purslane on rat liver injury induced by carbon tetrachloride. Saudi Pharmaceut J 16: 239-244.
3. Assinewe VA, Baum BR, Gagnon D & Arnason JT (2003). Phytochemistry of wild populations of Panax quinque-folius L. (North American Ginseng). J Agric Food Chem 51: 4549-4553.
4. Chan K, Islam MW, Kamil M, Radhakrishnan R, Zakaria MN, Habibullah M & Attas A (2000). The analgesic and anti-inflammatory effects of Portulaca oleracea L. subsp. Sativa (Haw.) celak. J Ethnopharmacol 73: 445-451.
5. Crozier A, Jaganath IB & Clifford MN (2009). Dietary phenolics: chemistry, bio-availability and effects on health. Nat. Prod. Rep. 26: 1001-1043.
6. Dobiasova M & Frohlich J (2001). The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esteri-fication rate in apoB-lipoprotein-depleted plasma (FERHDL). Clin Biochem 34: 583-588.
7. Guillou H, Martin PG & Pineau T (2008). Transcriptional regulation of hepatic fatty acid metabolism. Subcell Biochem 49: 3-47.
8. Hayashi K & Ito M (2002). Anti-diabetic action of low molecular weight chitosan in genetically obese diabetic KKAy mice. Biol Pharm Bull 25: 188-192.
9. Hildebrandt AL, Kelly-Sullivan DM & Black SC (2003). Antiobesity effects of chronic cannabinoid CB1 receptor antagonist treatment in dietinduced obese mice. Eur J Pharmacol 462: 125-32.
10. Hoyos M. Guerrero R, Cano J, Olivan F, Fabiani A, Perganeda G & Osuna C (2000). Serum cholesterol and lipid peroxidation are decreased by melatonin in diet induced hyper-cholesterolemic rats. J Pineal Res 28: 150-155.
11. Hu LF, Xu XY & Wang BQ (2003). Research and utilisation situation of Portulaca oleracea L in China. Prac J MED & Pharm 20: 315-316.
12. Hussein MA & Abdel-Gawad SM (2010). In vivo hepato-protective properties of purslane extracts on paracetamol-induced liver damage. Mal J Nutr 16: 161-170.
13. Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K & Tobe K (2006). Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 116: 1784-1792.
14. Kim JK, Fillmore JJ, Chen Y, Yu C, Moore IK & Pypaert M (2001).Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance. Proc Natl Acad Sci USA 98: 7522-7527.
15. Klein G, Kim J, Himmeldirk K, Cao Y& Chen X (2007). Antidiabetes and anti-obesity activity of Lagestroemia speciosa. Evid Based Complement Alternat Med 4: 401-407.
16. Lee A & Morley JE (1998). Metformin decreases food consumption and induces weight loss in subjects with obesity with type II non-insulin dependent diabetes. Obes Res 6: 47-53.
17. Liu L, Howe P, Zhou YF, Xu ZQ, Hocart C & Zhan R (2000). Fatty acids and beta-carotene in Australian purslane (Portulaca oleracea) varieties. J Chromatogr A 893: 207-213.
18. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF and Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419.
19. Meng FB & Wu RG (2008). Appraisal on medicinal values of Portulaca oleracea L. Forest Investig Des 1: 77-78.
20. Mohammad TB, Mohammad HB &Farhad M (2004). Anti-tussive effect of Portulaca oleracea L. in guinea pigs. Iran J Pharmaceut Res 3: 187-190.
21. Ohta Y, Sami M, Kanda T, Saito K, Osada K, Kata H (2006). Gene expression analysis of the anti-obesity effect by apple polyphenols in rats fed a high fat diet or a normal diet. J Oleo Sci 55: 305-14.
22. Park SH, Ko & Chung SH (2005). Euonymus alatus prevents the hyperglycemia and hyperlipidemia induced by high-fat diet in ICR mice. J Ethnopharmacol 102: 326-35.
23. Peksel A, Arisan I & Yanardag (2006). Antioxidant activities of aqueous extracts of purslane(Portulaca oleracea Subsp. Sativa L.). Ital J Food Sci 3: 295-308.
24. Procopiou M & Philippe J (2005). The metabolic syndrome and type 2 diabetes: epidemiological figures and country specificities. Cerebrovasc Dis 20: 2-8.
25. Rodriguez C, Mayo J, Sainz R, Antolin I, Herrera F, Martin V & Reiter R (2004). Regulation of antioxidant enzymes: A significant role for melatonin. J Pineal Res 36: 1-9.
26. Sakai N, Inada K, Okamoto M, Shizuri Y, Fukuyama Y & Portuloside A (1996). A monoterpene glucoside, from Portulaca oleracea. Phytochem 42: 1625-1631.
27. Simopoulos A, Tan D, Manchester L & Reiter R (2005). A plant source of omega -3 fatty acids and melatonin. J Pineal Res 39: 331-332.
28. Tomonori N, Tadashi H& Ichiro T (2007). A green tea extract high in catechins reduces body fat and cardiovascular risks in humans. Obesity 6: 1473-1483.
29. Tsuchida A, Yamauchi T, Takekawa S, Hada Y, Ito Y & Maki T(2005). Peroxisome proliferator-activated receptor (PPAR)a activation increases adiponectin receptors and reduces obesity-related inflammation in adipose tissue: comparison of activation of PPARa, PPARgamma, and their combination. Diabetes 54: 3358-70.
30. Sasaki Y, Suzuki W, Shimada T, Iizuka S, Nakamura S & Nagata M (2009). Dose dependent development of diabetes mellitus and nonalcoholic steato-hepatitis in monosodium glutamate-induced obese mice. Life Sci 85: 490-498.
31. Xin H L, Xu YF, Yue XQ, Hou YH, Li M & Ling CQ (2008). Analysis of chemical constituents in extract from Portulaca oleracea L. with GC-MS Method (In Chinese). Pharmaceut J Chin People's Liberat 24: 133-136.